Tomoyuki Araya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tomoyuki Araya has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
Kazuo Kasahara
Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan
18 shared publications- Toshiyuki Kita
Department of Respiratory Medicine NHO Kanazawa Medical Center Kanazawa Ishikawa Japan
13 shared publications Hazuki Takato
Department of Respiratory Medicine NHO Kanazawa Medical Center Kanazawa Japan
12 shared publicationsTakashi Sone
Department of Respiratory Medicine, Ishikawa Prefectural Central Hospital, 2 Chome-1, Kuratsukihigashi, Kanazawa, Ishikawa 920-8291, Japan
12 shared publicationsTakayuki Higashi
Department of Respiratory Medicine NHO Kanazawa Medical Center Kanazawa Japan
12 shared publicationsRyo Hara
Department of Respiratory Medicine NHO Kanazawa Medical Center Kanazawa Ishikawa Japan
11 shared publications
Latest Publications
- Open Access
- 21 April 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (4) , e70588
Positron Emission Tomography‐Negative Mediastinal Lymph Node Metastasis From Clear Cell Renal Cell Carcinoma 11 Years After Nephrectomy Diagnosed by Endobronchial Ultrasound‐Guided Transbronchial Needle Capillary Sampling
A 73‐year‐old man was referred for evaluation of mediastinal lymphadenopathy. He had undergone right nephrectomy for clear cell renal cell carcinoma (ccRCC; pT3aN0M0, stage III) 11 years earlier and had remained recurrence‐free without adjuvant therapy. Positron emission tomography/computed tomography (PET/CT) revealed an enlarged subcarinal lymph node which was non‐FDG avid. Bronchoscopy was performed to obtain a pathological diagnosis. Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) initially yielded bloody and inadequate specimens on rapid on‐site cytologic evaluation (ROSE). The sampling technique was therefore switched to endobronchial ultrasound‐guided transbronchial needle capillary sampling (EBUS‐TBNCS), and ROSE demonstrated adequate cellular material with atypical cells. Histopathology and immunohistochemistry confirmed metastatic ccRCC. This case highlights that metastatic ccRCC should be considered in PET‐negative mediastinal lymphadenopathy more than a decade after nephrectomy and that EBUS‐TBNCS may facilitate diagnostic tissue acquisition when conventional EBUS‐TBNA yields bloody specimens.
- 21 April 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (4) , e70588
Open AccessPositron Emission Tomography‐Negative Mediastinal Lymph Node Metastasis From Clear Cell Renal Cell Carcinoma 11 Years After Nephrectomy Diagnosed by Endobronchial Ultrasound‐Guided Transbronchial Needle Capillary Sampling
A 73‐year‐old man was referred for evaluation of mediastinal lymphadenopathy. He had undergone right nephrectomy for clear cell renal cell carcinoma (ccRCC; pT3aN0M0, stage III) 11 years earlier and had remained recurrence‐free without adjuvant therapy. Positron emission tomography/computed tomography (PET/CT) revealed an enlarged subcarinal lymph node which was non‐FDG avid. Bronchoscopy was performed to obtain a pathological diagnosis. Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) initially yielded bloody and inadequate specimens on rapid on‐site cytologic evaluation (ROSE). The sampling technique was therefore switched to endobronchial ultrasound‐guided transbronchial needle capillary sampling (EBUS‐TBNCS), and ROSE demonstrated adequate cellular material with atypical cells. Histopathology and immunohistochemistry confirmed metastatic ccRCC. This case highlights that metastatic ccRCC should be considered in PET‐negative mediastinal lymphadenopathy more than a decade after nephrectomy and that EBUS‐TBNCS may facilitate diagnostic tissue acquisition when conventional EBUS‐TBNA yields bloody specimens.
- Open Access
- 20 January 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (1)
Extensive Lymphadenopathy in an HIV ‐Negative Patient With Multidrug‐Resistant Tuberculosis
Tuberculous lymphadenitis is generally more severe in patients with HIV infection. We present an HIV‐negative patient with multidrug‐resistant tuberculosis who developed severe, extensive lymphadenitis involving multiple extrapulmonary regions. This clinical image highlights that marked lymph node involvement may occur in HIV‐negative patients presenting with pronounced systemic symptoms.
- 20 January 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (1)
Open AccessExtensive Lymphadenopathy in an HIV ‐Negative Patient With Multidrug‐Resistant Tuberculosis
Tuberculous lymphadenitis is generally more severe in patients with HIV infection. We present an HIV‐negative patient with multidrug‐resistant tuberculosis who developed severe, extensive lymphadenitis involving multiple extrapulmonary regions. This clinical image highlights that marked lymph node involvement may occur in HIV‐negative patients presenting with pronounced systemic symptoms.
- Open Access
- 19 January 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (1)
Severe Lung Abscess and Sepsis Caused by Klebsiella ozaenae in a Malnourished Patient With Psychiatric Disease
Severe infections caused by Klebsiella ozaenae are extremely rare, and their clinical characteristics remain poorly defined. We report a case of Klebsiella ozaenae sepsis with severe lung abscesses in a malnourished patient with psychiatric disease, requiring 3 months of antimicrobial therapy for complete resolution.
- 19 January 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (1)
Open AccessSevere Lung Abscess and Sepsis Caused by Klebsiella ozaenae in a Malnourished Patient With Psychiatric Disease
Severe infections caused by Klebsiella ozaenae are extremely rare, and their clinical characteristics remain poorly defined. We report a case of Klebsiella ozaenae sepsis with severe lung abscesses in a malnourished patient with psychiatric disease, requiring 3 months of antimicrobial therapy for complete resolution.
- Open Access
- 2 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1)
A Highly Uncommon Presentation: A Consecutive Three-Case Series of Malignant Ureteral Obstruction in Long-Term Survivors of Non-small Cell Lung Cancer
Malignant ureteral obstruction (MUO) is an exceptionally rare complication in non-small cell lung cancer (NSCLC), particularly among long-term survivors. We report three cases of MUO arising in patients with stage IV or recurrent NSCLC, all of whom had survived 3.6-4.0 years after their initial diagnosis. Two of the three cases harbored epidermal growth factor receptor (EGFR) mutations, and MUO in EGFR-mutated NSCLC has not been previously described, suggesting a potential association with prolonged survival under targeted therapy. All patients developed hydronephrosis and renal dysfunction requiring ureteral stent placement. Their clinical courses diverged: one EGFR-mutated patient maintained preserved renal function and remained free from urinary tract infection for three years and four months following stent placement, whereas the remaining two patients experienced rapid disease progression and died within months. These cases indicate that prompt recognition of MUO and early ureteral decompression may meaningfully improve symptoms and preserve renal function, thereby contributing to favorable clinical trajectories in selected long-term survivors. As patient survival continues to lengthen with modern systemic therapies, optimizing drainage strategies will become increasingly important.
- 2 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1)
Open AccessA Highly Uncommon Presentation: A Consecutive Three-Case Series of Malignant Ureteral Obstruction in Long-Term Survivors of Non-small Cell Lung Cancer
Malignant ureteral obstruction (MUO) is an exceptionally rare complication in non-small cell lung cancer (NSCLC), particularly among long-term survivors. We report three cases of MUO arising in patients with stage IV or recurrent NSCLC, all of whom had survived 3.6-4.0 years after their initial diagnosis. Two of the three cases harbored epidermal growth factor receptor (EGFR) mutations, and MUO in EGFR-mutated NSCLC has not been previously described, suggesting a potential association with prolonged survival under targeted therapy. All patients developed hydronephrosis and renal dysfunction requiring ureteral stent placement. Their clinical courses diverged: one EGFR-mutated patient maintained preserved renal function and remained free from urinary tract infection for three years and four months following stent placement, whereas the remaining two patients experienced rapid disease progression and died within months. These cases indicate that prompt recognition of MUO and early ureteral decompression may meaningfully improve symptoms and preserve renal function, thereby contributing to favorable clinical trajectories in selected long-term survivors. As patient survival continues to lengthen with modern systemic therapies, optimizing drainage strategies will become increasingly important.
- Open Access
- 17 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
More Than Five Years of Sustained Remission With Mepolizumab in Adolescent-Onset Eosinophilic Granulomatosis With Polyangiitis: A Case Report
Eosinophilic granulomatosis with polyangiitis (EGPA) typically affects middle-aged adults, and adolescent-onset disease is rare and scarcely documented in long-term real-world follow-up. We describe an 18-year-old woman with asthma who presented with fever, muscle pain, wet cough, and dyspnea. Laboratory tests showed marked leukocytosis (27,600/µL) with severe eosinophilia (17,940/µL), elevated creatine kinase, normal Krebs von den Lungen-6, elevated surfactant protein-D, markedly elevated serum immunoglobulin E, and negative proteinase 3- and myeloperoxidase-anti-neutrophil cytoplasmic antibody. Imaging revealed bilateral patchy infiltrates, and transbronchial lung biopsy demonstrated eosinophilic infiltration with granuloma formation and features of vasculitis, establishing the diagnosis of EGPA. Prednisolone 25 mg/day induced rapid improvement with normalization of eosinophils by day 12. She remained stable for nearly two years on low-dose prednisolone until asymptomatic eosinophilia recurred during tapering. Mepolizumab 300 mg every four weeks was then initiated, leading to immediate eosinophil normalization. Prednisolone was discontinued three years and 10 months after starting mepolizumab, and she has maintained remission for more than five years under continued therapy. This real-world case shows that, in adolescent-onset EGPA, where corticosteroids alone controlled disease for only two years, mepolizumab achieved sustained remission without significant adverse effects and enabled complete steroid withdrawal, underscoring its value as a long-term steroid-sparing strategy.
- 17 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Open AccessMore Than Five Years of Sustained Remission With Mepolizumab in Adolescent-Onset Eosinophilic Granulomatosis With Polyangiitis: A Case Report
Eosinophilic granulomatosis with polyangiitis (EGPA) typically affects middle-aged adults, and adolescent-onset disease is rare and scarcely documented in long-term real-world follow-up. We describe an 18-year-old woman with asthma who presented with fever, muscle pain, wet cough, and dyspnea. Laboratory tests showed marked leukocytosis (27,600/µL) with severe eosinophilia (17,940/µL), elevated creatine kinase, normal Krebs von den Lungen-6, elevated surfactant protein-D, markedly elevated serum immunoglobulin E, and negative proteinase 3- and myeloperoxidase-anti-neutrophil cytoplasmic antibody. Imaging revealed bilateral patchy infiltrates, and transbronchial lung biopsy demonstrated eosinophilic infiltration with granuloma formation and features of vasculitis, establishing the diagnosis of EGPA. Prednisolone 25 mg/day induced rapid improvement with normalization of eosinophils by day 12. She remained stable for nearly two years on low-dose prednisolone until asymptomatic eosinophilia recurred during tapering. Mepolizumab 300 mg every four weeks was then initiated, leading to immediate eosinophil normalization. Prednisolone was discontinued three years and 10 months after starting mepolizumab, and she has maintained remission for more than five years under continued therapy. This real-world case shows that, in adolescent-onset EGPA, where corticosteroids alone controlled disease for only two years, mepolizumab achieved sustained remission without significant adverse effects and enabled complete steroid withdrawal, underscoring its value as a long-term steroid-sparing strategy.
- Open Access
- 10 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Long-Term Stability of Allergic Bronchopulmonary Mycosis After Bronchoscopic Removal of Mucus Plugs: A Six-Year Follow-Up Case Report
A 37-year-old man with asthma under treatment presented with fever and dyspnea, accompanied by marked peripheral eosinophilia (10,400/µL) and elevated total immunoglobulin E (IgE) levels (463.2 IU/mL). Chest computed tomography demonstrated multiple mucus plugs in the right upper lobe and bilateral lower lobes, accompanied by central bronchiectasis. Bronchoscopy revealed mucus plugs in the tracheal bifurcation and lower bronchi. Cultures of the removed sputum and mucus plugs grew Penicillium citrinum. Pathology of the mucus plugs showed necrotic and degenerated cells, exudates, mucus, and Charcot-Leyden crystals. Based on these clinical, serological, and radiological findings, the diagnostic criteria for allergic bronchopulmonary mycosis (ABPM) were fulfilled. Following bronchoscopic removal of the mucus plugs led to rapid improvement without pharmacological therapy. No recurrence was observed for more than six years. This rare case suggests that bronchoscopic mucus plug removal may serve not only for diagnosis but also as an effective therapeutic option in selected patients with ABPM caused by Penicillium citrinum.
- 10 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Open AccessLong-Term Stability of Allergic Bronchopulmonary Mycosis After Bronchoscopic Removal of Mucus Plugs: A Six-Year Follow-Up Case Report
A 37-year-old man with asthma under treatment presented with fever and dyspnea, accompanied by marked peripheral eosinophilia (10,400/µL) and elevated total immunoglobulin E (IgE) levels (463.2 IU/mL). Chest computed tomography demonstrated multiple mucus plugs in the right upper lobe and bilateral lower lobes, accompanied by central bronchiectasis. Bronchoscopy revealed mucus plugs in the tracheal bifurcation and lower bronchi. Cultures of the removed sputum and mucus plugs grew Penicillium citrinum. Pathology of the mucus plugs showed necrotic and degenerated cells, exudates, mucus, and Charcot-Leyden crystals. Based on these clinical, serological, and radiological findings, the diagnostic criteria for allergic bronchopulmonary mycosis (ABPM) were fulfilled. Following bronchoscopic removal of the mucus plugs led to rapid improvement without pharmacological therapy. No recurrence was observed for more than six years. This rare case suggests that bronchoscopic mucus plug removal may serve not only for diagnosis but also as an effective therapeutic option in selected patients with ABPM caused by Penicillium citrinum.
- Open Access
- 26 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Hyperammonemic Encephalopathy Caused by Obstructive Urinary Tract Infection Due to Urease-Positive Corynebacterium riegelii in an Elderly Woman: A Case Report
Hyperammonemia typically results from hepatic dysfunction, but obstructive urinary tract infection (UTI) caused by urease-producing bacteria can rarely induce severe hyperammonemia and encephalopathy. We describe a 76-year-old woman with chronic voiding dysfunction who presented with fever and coma, with a markedly elevated serum ammonia level of 380 μg/dL despite normal liver function. Urinalysis revealed markedly alkaline urine and pyuria. Head computed tomography (CT) and magnetic resonance imaging showed no acute abnormalities. Abdominal CT demonstrated marked bladder distention and no findings suggestive of chronic liver disease. Bladder decompression and piperacillin/tazobactam therapy led to rapid improvement, with ammonia falling to 70 μg/dL and full recovery of consciousness within 48 hours. Urine culture later yielded Corynebacterium species, prompting the addition of vancomycin; the organism was subsequently identified as urease-positive Corynebacterium riegelii. Blood cultures remained negative, and a later plasma amino acid analysis showed no evidence of urea-cycle disorders. The patient had no recurrence of hyperammonemia or UTI during the four-year follow-up. Obstructive UTI due to urease-producing bacteria should be recognized as a reversible cause of acute encephalopathy in elderly patients with urinary retention.
- 26 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Open AccessHyperammonemic Encephalopathy Caused by Obstructive Urinary Tract Infection Due to Urease-Positive Corynebacterium riegelii in an Elderly Woman: A Case Report
Hyperammonemia typically results from hepatic dysfunction, but obstructive urinary tract infection (UTI) caused by urease-producing bacteria can rarely induce severe hyperammonemia and encephalopathy. We describe a 76-year-old woman with chronic voiding dysfunction who presented with fever and coma, with a markedly elevated serum ammonia level of 380 μg/dL despite normal liver function. Urinalysis revealed markedly alkaline urine and pyuria. Head computed tomography (CT) and magnetic resonance imaging showed no acute abnormalities. Abdominal CT demonstrated marked bladder distention and no findings suggestive of chronic liver disease. Bladder decompression and piperacillin/tazobactam therapy led to rapid improvement, with ammonia falling to 70 μg/dL and full recovery of consciousness within 48 hours. Urine culture later yielded Corynebacterium species, prompting the addition of vancomycin; the organism was subsequently identified as urease-positive Corynebacterium riegelii. Blood cultures remained negative, and a later plasma amino acid analysis showed no evidence of urea-cycle disorders. The patient had no recurrence of hyperammonemia or UTI during the four-year follow-up. Obstructive UTI due to urease-producing bacteria should be recognized as a reversible cause of acute encephalopathy in elderly patients with urinary retention.
- Open Access
- 20 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Late Recurrence of Breast Cancer Nearly 30 Years After Surgery: Mediastinal and Hilar Lymph Node Metastases Diagnosed Using Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration
Late recurrence of breast cancer occurring more than two decades after curative surgery is rare, but in the era of prolonged survival, clinicians may increasingly encounter such cases. Mediastinal or hilar recurrence may radiologically mimic primary lung cancer; however, histological confirmation using endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) enables accurate diagnosis with minimal invasiveness. We report the cases of two patients who developed mediastinal and hilar lymph node metastases nearly 30 years after breast cancer surgery, for whom EBUS-TBNA played a crucial diagnostic role. A 68-year-old woman with a history of right mastectomy for stage I (T1aN0M0) breast cancer 30 years earlier presented with cough and hemoptysis. Chest computed tomography revealed multiple pulmonary nodules, right hilar lymphadenopathy, and sclerotic bone lesions. Fluorodeoxyglucose positron emission tomography/computed tomography showed intense uptake in the right hilar lymph nodes and bones, whereas pulmonary nodules demonstrated only mild uptake. EBUS-TBNA of station 12R revealed adenocarcinoma positive for estrogen and progesterone receptors and negative for human epidermal growth factor receptor 2, confirming metastatic breast carcinoma. The patient was treated with abemaciclib plus fulvestrant, achieving durable disease control for 2.5 years. A 70-year-old woman who had undergone left mastectomy 27 years earlier presented with a dry cough. EBUS-TBNA of stations 4R and 7 confirmed metastatic breast carcinoma. She received nab-paclitaxel followed by trastuzumab deruxtecan, achieving disease control for 20 months. These cases demonstrate that even very late recurrences nearly three decades after surgery can achieve prolonged survival when appropriately diagnosed and optimally treated. EBUS-TBNA is a valuable and minimally invasive diagnostic tool for confirming such a late recurrence.
- 20 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Open AccessLate Recurrence of Breast Cancer Nearly 30 Years After Surgery: Mediastinal and Hilar Lymph Node Metastases Diagnosed Using Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration
Late recurrence of breast cancer occurring more than two decades after curative surgery is rare, but in the era of prolonged survival, clinicians may increasingly encounter such cases. Mediastinal or hilar recurrence may radiologically mimic primary lung cancer; however, histological confirmation using endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) enables accurate diagnosis with minimal invasiveness. We report the cases of two patients who developed mediastinal and hilar lymph node metastases nearly 30 years after breast cancer surgery, for whom EBUS-TBNA played a crucial diagnostic role. A 68-year-old woman with a history of right mastectomy for stage I (T1aN0M0) breast cancer 30 years earlier presented with cough and hemoptysis. Chest computed tomography revealed multiple pulmonary nodules, right hilar lymphadenopathy, and sclerotic bone lesions. Fluorodeoxyglucose positron emission tomography/computed tomography showed intense uptake in the right hilar lymph nodes and bones, whereas pulmonary nodules demonstrated only mild uptake. EBUS-TBNA of station 12R revealed adenocarcinoma positive for estrogen and progesterone receptors and negative for human epidermal growth factor receptor 2, confirming metastatic breast carcinoma. The patient was treated with abemaciclib plus fulvestrant, achieving durable disease control for 2.5 years. A 70-year-old woman who had undergone left mastectomy 27 years earlier presented with a dry cough. EBUS-TBNA of stations 4R and 7 confirmed metastatic breast carcinoma. She received nab-paclitaxel followed by trastuzumab deruxtecan, achieving disease control for 20 months. These cases demonstrate that even very late recurrences nearly three decades after surgery can achieve prolonged survival when appropriately diagnosed and optimally treated. EBUS-TBNA is a valuable and minimally invasive diagnostic tool for confirming such a late recurrence.
- Open Access
- 17 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Tumor-to-Tumor Metastasis of Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma to a Meningioma 14 Years After Curative Lobectomy: A Case Report
Tumor-to-tumor metastasis is a rare oncologic phenomenon in which one primary malignancy metastasizes into another distinct neoplasm. While meningiomas are the most common recipients, this route of recurrence has not been reported in epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma. A 74-year-old female patient, who had remained disease-free for 14 years after undergoing right upper lobectomy for stage IA (pT1N0M0) lung adenocarcinoma, presented with headache and vomiting. Brain MRI demonstrated a 30 × 35 mm mass in the left parietal lobe with both solid and cystic portions abutting the dura and associated with surrounding edema, which was subsequently resected. Histopathological examination showed an admixture of meningioma and adenocarcinoma components, consistent with tumor-to-tumor metastasis. Immunohistochemistry revealed adenocarcinoma cells positive for thyroid transcription factor-1, Napsin A, and cytokeratin 7, supporting a pulmonary origin. Molecular testing identified an EGFR exon 19 deletion in both the intracranial lesion and the primary lung adenocarcinoma resected 14 years earlier, confirming a shared clonal origin. Following diagnosis, the patient received postoperative radiation therapy followed by osimertinib, and she remains recurrence-free three years after surgery. This case highlights an exceptionally rare pattern of recurrence, tumor-to-tumor metastasis of EGFR-mutated lung adenocarcinoma after right upper lobectomy into a meningioma, occurring 14 years after curative surgery. Oncologists should recognize that EGFR-mutated lung cancer can recur after an exceptionally long disease-free interval through rare metastatic patterns such as tumor-to-tumor metastasis.
- 17 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Open AccessTumor-to-Tumor Metastasis of Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma to a Meningioma 14 Years After Curative Lobectomy: A Case Report
Tumor-to-tumor metastasis is a rare oncologic phenomenon in which one primary malignancy metastasizes into another distinct neoplasm. While meningiomas are the most common recipients, this route of recurrence has not been reported in epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma. A 74-year-old female patient, who had remained disease-free for 14 years after undergoing right upper lobectomy for stage IA (pT1N0M0) lung adenocarcinoma, presented with headache and vomiting. Brain MRI demonstrated a 30 × 35 mm mass in the left parietal lobe with both solid and cystic portions abutting the dura and associated with surrounding edema, which was subsequently resected. Histopathological examination showed an admixture of meningioma and adenocarcinoma components, consistent with tumor-to-tumor metastasis. Immunohistochemistry revealed adenocarcinoma cells positive for thyroid transcription factor-1, Napsin A, and cytokeratin 7, supporting a pulmonary origin. Molecular testing identified an EGFR exon 19 deletion in both the intracranial lesion and the primary lung adenocarcinoma resected 14 years earlier, confirming a shared clonal origin. Following diagnosis, the patient received postoperative radiation therapy followed by osimertinib, and she remains recurrence-free three years after surgery. This case highlights an exceptionally rare pattern of recurrence, tumor-to-tumor metastasis of EGFR-mutated lung adenocarcinoma after right upper lobectomy into a meningioma, occurring 14 years after curative surgery. Oncologists should recognize that EGFR-mutated lung cancer can recur after an exceptionally long disease-free interval through rare metastatic patterns such as tumor-to-tumor metastasis.
- Open Access
- 14 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Hypersensitivity Pneumonitis-Like Drug-Induced Interstitial Lung Disease Caused by Pegylated Liposomal Doxorubicin: A Case Report
Drug-induced interstitial lung disease (DI-ILD) encompasses a wide spectrum of imaging and histopathologic patterns, sometimes resembling hypersensitivity pneumonitis (HP). Pegylated liposomal doxorubicin (PLD, Doxil®) is a nanoparticulate formulation of doxorubicin designed to reduce systemic toxicity, and pulmonary toxicity is rarely documented. We report a 62-year-old woman with recurrent ovarian carcinoma who developed fever and erythema after the third cycle of PLD, followed by diffuse pulmonary infiltrates. She had no history of allergy, lung disease, or environmental antigen exposure. On admission, chest radiography revealed bilateral fine granular opacities, and high-resolution computed tomography demonstrated diffuse centrilobular ground-glass nodules predominantly in the upper lobes. Bronchoalveolar lavage showed marked lymphocytosis with elevated total cell counts, and transbronchial lung biopsy revealed noncaseating epithelioid granulomas with lymphocytic infiltration, consistent with an HP-like pattern. Microbiologic and autoimmune evaluations were negative. Based on the temporal association with PLD administration, compatible imaging and histopathologic findings, and exclusion of other etiologies, a diagnosis of HP-like DI-ILD induced by PLD was made. Prednisolone 50 mg daily led to rapid defervescence and remarkable radiologic improvement within two weeks, followed by complete remission after tapering and no recurrence during 4.5 months of follow-up until death from progressive ovarian cancer. This case highlights that PLD, though considered relatively safe, can induce HP-like DI-ILD, and prompt recognition with appropriate corticosteroid therapy may achieve favorable outcomes. Clinicians should remain vigilant for this rare but potentially severe pulmonary toxicity.
- 14 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Open AccessHypersensitivity Pneumonitis-Like Drug-Induced Interstitial Lung Disease Caused by Pegylated Liposomal Doxorubicin: A Case Report
Drug-induced interstitial lung disease (DI-ILD) encompasses a wide spectrum of imaging and histopathologic patterns, sometimes resembling hypersensitivity pneumonitis (HP). Pegylated liposomal doxorubicin (PLD, Doxil®) is a nanoparticulate formulation of doxorubicin designed to reduce systemic toxicity, and pulmonary toxicity is rarely documented. We report a 62-year-old woman with recurrent ovarian carcinoma who developed fever and erythema after the third cycle of PLD, followed by diffuse pulmonary infiltrates. She had no history of allergy, lung disease, or environmental antigen exposure. On admission, chest radiography revealed bilateral fine granular opacities, and high-resolution computed tomography demonstrated diffuse centrilobular ground-glass nodules predominantly in the upper lobes. Bronchoalveolar lavage showed marked lymphocytosis with elevated total cell counts, and transbronchial lung biopsy revealed noncaseating epithelioid granulomas with lymphocytic infiltration, consistent with an HP-like pattern. Microbiologic and autoimmune evaluations were negative. Based on the temporal association with PLD administration, compatible imaging and histopathologic findings, and exclusion of other etiologies, a diagnosis of HP-like DI-ILD induced by PLD was made. Prednisolone 50 mg daily led to rapid defervescence and remarkable radiologic improvement within two weeks, followed by complete remission after tapering and no recurrence during 4.5 months of follow-up until death from progressive ovarian cancer. This case highlights that PLD, though considered relatively safe, can induce HP-like DI-ILD, and prompt recognition with appropriate corticosteroid therapy may achieve favorable outcomes. Clinicians should remain vigilant for this rare but potentially severe pulmonary toxicity.